menu
    • menu

    Company profile for Viridian Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Viridian Therapeutics is advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s patient-centric model of innovation leverages proven biology and technology to efficiently allocate research and development resources while addressing strategic gaps related to access, delivery, quality of life, and efficacy in therapeutic areas of focus. Viridian’s most advanc...
    Viridian Therapeutics is advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s patient-centric model of innovation leverages proven biology and technology to efficiently allocate research and development resources while addressing strategic gaps related to access, delivery, quality of life, and efficacy in therapeutic areas of focus. Viridian’s most advanced program, VRDN-001, is an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody in development for thyroid eye disease (TED).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Viridian TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    221 Crescent Street Suite 401 Waltham, MA 02453
    Telephone
    Telephone
    617-272-4600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.viridiantherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/viridiantx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ViridianThera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viridian Therapeutics Issues Inducement Grants Per Nasdaq LR
    Viridian Therapeutics Issues Inducement Grants Per Nasdaq LR

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107767864/en/Viridian-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Viridian Therapeutics Unveils Q3 2025 Financials & Recent
    Viridian Therapeutics Unveils Q3 2025 Financials & Recent

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105575655/en/Viridian-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Highlights-Recent-Progress

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    Viridian Therapeutics Submits Veligrotug (BLA) For Thyroid Eye
    Viridian Therapeutics Submits Veligrotug (BLA) For Thyroid Eye

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028721424/en/Viridian-Therapeutics-Announces-Successful-October-Submission-of-Biologics-License-Application-BLA-to-U.S.-FDA-for-Veligrotug-in-Thyroid-Eye-Disease

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Viridian Pharma Prices $251M Public Stock Offering
    Viridian Pharma Prices $251M Public Stock Offering

    22 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-22/viridian-therapeutics-announces-pricing-of-251-million-public-offering-of-shares-of-common-stock

    PHARMIWEB
    22 Oct 2025
    Share Share
    Viridian Therapeutics Plans Public Offering
    Viridian Therapeutics Plans Public Offering

    21 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-21/viridian-therapeutics-announces-proposed-underwritten-public-offering

    PHARMIWEB
    21 Oct 2025
    Share Share
    Viridian Therapeutics Secures $300M Royalty Financing With DRI
    Viridian Therapeutics Secures $300M Royalty Financing With DRI

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/viridian-therapeutics-announces-royalty-financing-with-dri-healthcare-for-up-to-300-million

    PHARMIWEB
    20 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search